Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir

doi:10.3748/wjg.v19.i43.7671

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4703)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

309

HTML

2480

Figures (1-6)

194

Tables (1-2)

135

Sum=3118

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

931

Download

654

Sum=1585

Nov 21, 2013 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Nov 21, 2013; 19(43): 7671-7679
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7671

Full Size Figure Download Figure

Figure 2 Proportion of patients with undetectable serum hepatitis B virus DNA (< 12 IU/mL) over time. ¹Undetectable < 12 IU/mL. LAM: Lamivudine; ADV: Adefovire; HBV: High hepatitis B virus; LdT: Telbivudine; PCR: Polymerase chain reaction.

Citation: Park H, Park JY, Kim SU, Kim DY, Han KH, Chon CY, Ahn SH. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir. World J Gastroenterol 2013; 19(43): 7671-7679
URL: https://www.wjgnet.com/1007-9327/full/v19/i43/7671.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i43.7671